Reports Q3 revenue EUR 4.3B vs. EUR 4.38B last year. Comparable order intake grew 8%. The company said, “In this quarter we maintained our momentum, with AI-powered innovations and long-term partnerships making a real difference for patients and consumers. We drove strong order intake and accelerated sales growth, with sustained strength in North America. We expanded margin through innovation, focused execution and cost discipline, remaining firmly on-track as we navigate an uncertain macro environment including tariffs.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHG:
- PHG Earnings this Week: How Will it Perform?
- Philips, Hoag, Orange County announce 10-year strategic collaboration
- Philips announces late-breaking results from iMODERN trial at TCT conference
- FDA issues warning letter to Philips on device facilities
- Philips shares drop 6% after FDA sends warning letter
